A 5488 New Jersey General Assembly · 2022-2023 Regular Session

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances; requires reporting of xylazine prescriptions.

Bill status in committee 1 of 4 stages cleared
Introduction
May 2023
Committee Review
Floor Vote
Governor
Introduced May 18, 2023 Last action May 18, 2023
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
May 18, 2023
Introduced
Introduced in the Assembly, Referred to Assembly Judiciary Committee
lower
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
KJ
Kevin J. Rooney
RRepublican
NJ
40